Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.

Effects of novel isoform-selective phosphoinositide 3-kinase inhibitors on natural killer cell function.
复制标题

DOI:
10.1371/journal.pone.0099486
复制
发表时间:
2014
期刊:
影响因子:
3.7
通讯作者:
Fruman DA
Fruman DA
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Yea SS;So L;Mallya S;Lee J;Rajasekaran K;Malarkannan S;Fruman DA

文献摘要

参考文献

相似文献

Phosphoinositide 3-kinases (PI3Ks) are promising targets for therapeutic development in cancer. The class I PI3K isoform p110α has received considerable attention in oncology because the gene encoding p110α (PIK3CA) is frequently mutated in human cancer. However, little is known about the function of p110α in lymphocyte populations that modulate tumorigenesis. We used recently developed investigational inhibitors to compare the function of p110α and other isoforms in natural killer (NK) cells, a key cell type for immunosurveillance and tumor immunotherapy. Inhibitors of all class I isoforms (pan-PI3K) significantly impaired NK cell-mediated cytotoxicity and antibody-dependent cellular cytotoxicity against tumor cells, whereas p110α-selective inhibitors had no effect. In NK cells stimulated through NKG2D, p110α inhibition modestly reduced PI3K signaling output as measured by AKT phosphorylation. Production of IFN-γ and NK cell-derived chemokines was blocked by a pan-PI3K inhibitor and partially reduced by a p110δinhibitor, with lesser effects of p110α inhibitors. Oral administration of mice with MLN1117, a p110α inhibitor in oncology clinical trials, had negligible effects on NK subset maturation or terminal subset commitment. Collectively, these results support the targeting of PIK3CA mutant tumors with selective p110α inhibitors to preserve NK cell function.
DOI: 10.1016/j.cell.2013.04.031
发表时间: 2013-05-23
期刊: Cell
影响因子: 64.5
作者:
Fritsch R;de Krijger I;Fritsch K;George R;Reason B;Kumar MS;Diefenbacher M;Stamp G;Downward J
通讯作者: Downward J
DOI: 10.1371/journal.pone.0040852
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Putz EM;Prchal-Murphy M;Simma OA;Forster F;Koenig X;Stockinger H;Piekorz RP;Freissmuth M;Müller M;Sexl V;Zebedin-Brandl E
通讯作者: Zebedin-Brandl E
DOI: 10.1158/0008-5472.can-09-2525
发表时间: 2010-02-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Edgar, Kyle A.;Wallin, Jeffrey J.;Belvin, Marcia
通讯作者: Belvin, Marcia
DOI: 10.1111/j.1349-7006.2007.00580.x
发表时间: 2007-10-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者:
Kong, Dexin;Yamori, Takao
通讯作者: Yamori, Takao
DOI: 10.3389/fimmu.2012.00256
发表时间: 2012
影响因子: 7.3
作者:
Puri KD;Gold MR
通讯作者: Gold MR